NCT01950312View on ClinicalTrials.gov

The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
Autoimmune Inner Ear Disease
Interventions
DRUG

gevokizumab

Trial Locations (1)

11040

Long Island Jewish Medical Center, Hearing & Speech Center, New Hyde Park

Sponsors
All Listed Sponsors
collaborator

Feinstein Institute for Medical Research

OTHER

collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

XOMA (US) LLC

INDUSTRY

NCT01950312 - The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease | Biotech Hunter | Biotech Hunter